Menene mafi kyawun allunan Actovegin ko injections?

Abin ƙyamar doping, dalilin ɗaurin likita, barazanar cutar mahaukaci da kuma tabbacin masana'antun cewa gwaji na asibiti ba su da mahimmanci. Duk wannan ya shafi wani magani, wanda yana cikin jagororin tallace-tallace a Rasha - Actovegin. A cikin kwatancensa “Abin da suke yi mana”, Indicator.Ru ya fahimci ko wannan maganin yana aiki kuma yana bayyana dalilin da yasa aka haramta shi a Amurka da Kanada.

Binciken tallace-tallace na kantin magani na magunguna ya nuna cewa a cikin lokacin sanyi a shekara, fifiko ga magunguna don mura da sauran cututtukan matsananciyar cutar, irin su Ingavirin, wanda muka yi magana a cikin labarin da ya gabata na rubric. A watan Maris da Afrilu, a cewar kungiyar DSM, wani magani daban, Actovegin, wanda ya zama kashi 0.76-0.77% na yawan tallace-tallace a cikin waɗannan watannin, ya zo a kan layi na farko.

An tsara wannan magani don lura da cututtukan jijiyoyin jiki da cuta na kwakwalwa, raunin jijiyoyin jini da tasirinsu (ƙoshin trophic), ƙonewa da raunuka, raunin daji da kuma a cikin yanayin rikicewar girma na tayi a cikin mata masu ciki. Kamfanin kamfanin Sotex ne ya kirkireshi, mallakin kamfanin Protek, wanda, a nasa, ya zama kamfanin Takeda Pharmaceutical, daya daga cikin kamfanoni 15 na duniya na kera magunguna. A kan gidan yanar gizo na jihar rajista na magunguna, an gabatar da miyagun ƙwayoyi a fannoni da yawa: maganin shafawa, mala'ikan, mafita don allura da kuma jiko, har ma da manya-manyan abubuwa (a cikin sashin "magungunan magunguna").

Generics: karya ne ko ceto?

Actovegin ya tashi a matsayin mai ƙira (magani ne da ake siyarwa a ƙarƙashin sunan alama wanda ya sha bamban da asalin sunan mallaka na kamfanin haɓakawa - kimanin Mai nuna alama.Ru) wani magani - Solcoseryl, wanda aka kirkira tun 1996 daga kamfanin Swiss na Solco. Patent na kowane magani ya ƙare akan lokaci, kuma wani kamfani na iya fara ƙirƙirar shi ƙarƙashin sunan sa, kuma da alama zai fi araha sayar da shi, saboda ba za a daina kwafin samfurin ba. Mai araha da rahusawa farashi na zama cetattu na aminci ga ƙasashen duniya na uku, saboda haka samar da tallafi daga Hukumar Lafiya ta Duniya yake.

Rashin daidaituwa na ƙwayoyin cuta shine rashin gwaji na asibiti (sabanin nau'in alama), bambance-bambance masu yuwu a cikin inganci da sauran magabata, idan aka kwatanta da na asali, saboda abin da sakamako masu illa na iya faruwa. Tare da duk waɗannan gazawar, farashin magani na iya bambanta sosai, har ma masana na WHO sun lura cewa irin wannan maye ya fi komai kyau.

Maganin Solcoseryl na asali da kansa ya fadi cikin manyan nazarin magunguna biyu na Cochrane Library, wanda ke tattara shaidar ingancin fasahar likita da magunguna. Ofayansu yana ma'amala game da lura da ƙananan raunuka na ƙafa a cikin mutane da ke fama da cutar sikila ta amfani da nau'ikan wakilai shida waɗanda aka yi amfani da su a waje (sutura don raunuka, maganin shafawa) da ciki, ciki har da cikin ciki. Baya ga Solcoseryl, jerin magungunan da aka yi nazari sun haɗa da bitamin-kamar abu L-carnitine, isoxuprin, arginine butyrate, pegides na RGD da maganin rigakafi na gida. Binciken ya fahimci fa'idodin duk kayan aikin da aka lissafa don lura da ƙananan raunuka na ƙafa a cikin cutar sikila saboda ƙimar samfurin kaɗan da yiwuwar ƙaurarsa.

Wani bita ya shafi matsalolin ci gaban tayin yayin daukar ciki. Mawallafin sun kammala cewa akwai 'ƙaramin shaida' cewa Solcoseryl, galactose, glucose, ko carnitine da mata masu juna biyu ke ci suna taimakawa wajen magance wannan matsalar ta kowace hanya. Amsar tambayar ko kwafin na iya zama mafi kyau fiye da na asali, ga alama, ba shi da tushe. A wannan gaba, mutum zai iya dakatar da kara karatu, amma ba za mu nuna son kai ba. Mene ne idan lalatattun abubuwa da bambance-bambancen da aka samu daga Solcoseryl ya sa ya fi tasiri?

Daga me, daga wane?

Aiki sashi na miyagun ƙwayoyi yana zubar da jini na hemodialysate na jinin maraƙi, wato, rashin samun sunadarai da sauran manyan ƙasusuwa, fiye da kilogram 5, barbashi. Dangane da umarnin, wannan cakuda abubuwa yana inganta aikin ATP (adenosine triphosphoric acid - wani abu wanda kwayar ta adana makamashi) a cikin "tsire-tsire masu ƙwaƙwalwar sel", mitochondria, kuma yana haɓaka yawan oxygen ta sel. Wadanne abubuwa ne a cikin cakuda ke aiki ta wannan hanyar ma'anar moot, amma an ɗauka cewa waɗannan inositol phosphooligosaccharides ne.

An bayyana matakan samar da Actovegin akan getactovegin.com (ko dai na masana'antun magunguna ne ko masu siyarwa, babu makawa babu alamun hakan), inda aka ce) tsaftacewa da yawa tare da tacewa yana sanya maganin ya zama mai lafiya. Wannan labarin, ɗayan adadin takardun kimiyya, yana tabbatar da tasiri na miyagun ƙwayoyi da gaskiyar cewa yana iya yin aiki kamar insulin. Koyaya, mafi yawan nassoshi suna haifar da nazarin ayyukan miyagun ƙwayoyi a cikin al'adun ƙwayoyin haɗin haɗi: mai (adipocytes) ko "fibrous" (fibroblasts) bera ko beraye. Wannan matakin na gwaji yana da matukar muhimmanci, amma likitoci ba za su iya iyakance shi kawai ba.

Idan aka kalli shafin yanar gizon kamfanin Takeda Pharmaceutical a Turanci, ba za mu sami wani ambaton Actovegin a cikin jerin magungunan da kamfanin ya sayar ba. A cikin gidan yanar gizon yanar gizon Takeda Russia - kamfanin CIS, yana kan jerin magungunan da aka sayar da takardar sayan magani. Koyaya, hanyar haɗi zuwa shafin yanar gizon da miyagun ƙwayoyi kanta actovegin.ru tana jujjuya mu zuwa tashar yanar gizo ta http://nevrologia.info, kuma rubuta ta hanyar harafin k yana kaiwa ga rukunin yanar gizon wanda mai shi "ya zaɓi ɓoye bayanin shafin" (http://www.aktovegin.ru). Bari mu ga abin da kasidu na kimiyya daga manyan masana wallafe wallafen kimiyya suka gaya mana.

Da aka jera (ba) da aka jera

Akwai bincike da yawa game da ingancin Actovegin: bincike kan tushen labaran kimiyya PubMed ya ba da yawa kamar 133 labarai, waɗanda aka buga daga 1977 zuwa 2016. A cikin su 19 - sake dubawa. Binciken mujallar British Journal of Sports Medicine (tasirin tasirin 6.724) ya kammala da cewa kawai iyakataccen shaida ne kawai aka samu game da tasirin allurar cutar ciki ta Actovegin don magance raunin hamstring.

Yin bita daga mujallar Diabetes Obesity & Metabolism (factor 6.198), kimantawa sakamakon tasirin magunguna daban-daban akan cutar sankarau (wata cuta mai amfani da jijiyoyi sakamakon lalacewar kananan tasoshin ruwa da kuma karancin jini ga jijiyoyin jijiya), ya kammala da cewa magungunan sun hada da na ukun ( kashi na karshe) na gwaji na asibiti, babu wanda ya hada da Actovegin, FDA (Hukumar Kula da Abinci da Magunguna, Gudanar da Abinci da Magunguna) da Hukumar Kula da Lafiya ta Turai saboda matsalar tasirin ivnosti.

Gabaɗaya, yawancin karatun ana buga su a cikin Jamusanci, ko a cikin Rashanci, ko a cikin sauran ƙananan mujallu na ƙasa. Misali, labarin daya kawo rahoton cewa shan Actovegin yana taimakawa tare da karancin iskar oxygen a cikin tayin koda ya bayyana a Labaran Likita na Georgia. Ta fito a cikin 2006, a wannan lokacin tasirin tasirin mujallar ya kasance 0.07. Samfurar ta kasance kaɗan, kuma daga cikin mata 36, ​​ƙaddamar da Actovegin, glucose da bitamin C ya taimaka 24 kawai.

Wani binciken da ke bayyana tasirin magani a kan marasa lafiya da ke fama da cutar ciwon sukari, wanda aka buga a cikin Rashanci a cikin mujallar Ingantaccen Magunguna, an yi shi ne a kan samfurin mutane 500 - marasa lafiya na Asibitin Clinical Vidnovsky. Aikin ya nuna cewa rukunin da suke amfani da Actovegin suna da hancin edema da sauri kuma yawan zafin jiki na yankin da abin ya shafa ya ragu. Koyaya, a wannan yanayin, likitocin ba suyi amfani da hanyar makanta biyu ba, lokacin da mara lafiya da masanin kimiyya ba su san wanda yake karɓar maganin ba kuma wanene placebo har zuwa ƙarshen gwaje-gwaje.

A irin wannan yanayin, likita zai iya ɗaukar hankali ko da gangan ya ba da magani ga mutanen da ke da tsinkaye mafi dacewa, wanda zai gurɓata sakamakon (bayanin kula a mahaifa cewa tasirin littafin shine 0.142). Wani ɓangare na binciken, ko dai a cikin shekarun da suka gabata (ana aiwatar da su daga ƙarshen karni na bakwai zuwa 1990s), ko don wasu dalilai, yana da wuya a sami gaba ɗayan su, kodayake ana ambaton su kuma ana amfani da hanyar makafi mai sarrafa sau biyu a cikin sunayensu (alal misali, duba wannan binciken).

A halin yanzu, Kamfanin Takeda Pharmaceutical yana gudanar da bincike mai zurfi, makafi biyu, mai sarrafa hoto game da tasirin Actovegin, wanda samfurin 500 na marasa lafiya bayan bugun zuciya (daga asibitoci a Rasha, Belarus, Kazakhstan) ana daukar ma'aikata, amma har zuwa yanzu kawai an buga shirinsa da zane.

Nazarin 45 na Actovegin suna kan jerin gwaji na asibiti na Cochrane, amma duba daya ne kawai. Dangane da wannan bita, bisa ga bayanai daga gwaji na asibiti tara, rufe jimlar marasa lafiya 697, tare da kumburi da jijiyoyin Achilles, ana kuma daukar Actovegin, tare da sauran hanyoyin magani. Marubutan masu bita sun kammala cewa wannan magani 'yana da kwarjini,' 'amma yanayin tsananin yanayin marasa lafiyar da aka yi masu magani ya rikitasu, kuma samfurin yayi kadan. Amma kusa da wannan bita, wanda aka buga a 2001, alama ce ta WITHDRAWN ("an sake maimaita ta") a cikin 2011. Me zai iya zama dalilin wannan shawarar?

Rashin daidaito, Kurkuku da Cutar Madow

A cikin 2000, Actovegin ya kasance a tsakiyar abin kunya. An zargi mahalarta gasar tseren keke ta Tour de Faransa, ciki har da Lance Armstrong, wanda ta yi nasara a karo na bakwai (USADA v. Armstrong, shawarar da aka yanke shawara, sashi na IV B 3.e (shafi 42-45) (USADA 10), ana tuhumar su da yin amfani da shi tare da sauran magungunan doping. Oktoba 2012)). Duk da gaskiyar cewa yana da wuyar gano burbushi na wannan magani a cikin jini (jinin namu yana dauke da abubuwa iri ɗaya), kwafin magungunan da aka samo sune dalilin cajin. Koyaya, kamar yadda ƙarin karatuna suka nuna (kodayake ba a buga shi a cikin mafi girman tasirin rahoton Jaridar International Journal of Sports Medicine ba), wannan magani ba ya taimaka wa masu motsa jiki inganta ayyukan su.

Amma amfani da magani na dubura ta 'yan wasa ba su kare ba. An ambaci shari'ar girgiza anaphylactic a cikin mai keke bayan an yi kokarin kula da raunin da ya yi da Actovegin, amma daga baya ya zama cewa girgizar ta kasance mai yiwuwa ce, saboda zubar da jini, wataƙila ba shi da alaƙa da wannan maganin.

A watan Yulin 2011, gidan yanar gizon FDA ya ba da sanarwar yanke hukuncin wani mazaunin Toronto mai shekaru 51 Anthony Galea, wanda ya yi aiki tare da 'yan wasa (wannan lokacin, kwallon kafa da kwallon kwando) da kuma sanya magunguna ba bisa ka'ida ba: Actovegin da hormone girma na mutum. Daga cikin wasu abubuwa, likita ya yi aiki ba tare da izini na musamman daga kwararrun likita ba. Saboda wannan, an yanke masa hukuncin shekaru uku a kurkuku, tarar dala dubu 250 da kuma kwace kadarori a cikin dala dubu 275.

Rubuce-rubucen iri ɗaya ɗin sun nuna cewa duka magungunan 'ba a amince da su ba ga wani amfanin mutum. Dalilin wannan haramcin shine mummunar haɗarin kamuwa da cuta tare da cututtukan prion waɗanda ke shafar tsarin juyayi na mammalian. A cikin shanu, wannan shine encephalopathy na spongiform (shi ma cutar mahaukaci ne), kuma nau'in ɗan adam ana kiran shi cutar Creutzfeldt-Jakob. Sanadin cututtukan prion wani furotin ne da ba daidai ba, wanda ke “lalata” sauran sunadarai tare da irin sa, wanda yake haifar da lalacewar ƙwayar jijiya. Mutuwar cikin lokuta masu rauni kusan kashi 85% ne, yayin da mace-mace mai rauni ba ta da magani ko kaɗan.

Anyi bayanin ɓarkewar sabon sigar jim kaɗan kafin, a 2009. Don kare mutane daga sababbin cututtuka, an sanya dokar hana shigowa da shigo da magunguna tare da abubuwan da suka shafi dabbobi a Amurka da Kanada wanda za a iya yada kwayar ta prion. Halin girma na jiki wanda aka samo daga ƙwayar pituitary da kayan abinci na tushen dabba shima suna kan wannan jerin.

Koyaya, wannan haramcin da kuma zargin wasu lokuta game da kayan aikin su idan babu tabbataccen hujja mara iyaka na ingancin ba ya dame masu rarraba magunguna a cikin kasashen CIS.

Shugaban Rasha-CIS Josten Davidsen ya ce a cikin wata tattaunawa da Kommersant game da gina sabbin masana'antar kamfani a yankin Yaroslavl. Me zai hana mu yi? Domin ba ma jin bukatar yin hakan. Mun ga cewa maganin yana cikin buƙatun likitocin Rasha, suna ba da shawarar ga marasa lafiya. Wannan lamari ne mai mahimmanci, tunda likitoci a Rasha sun kasance masu kiyayewa sosai kuma suna bin sanannun dabarun magani da ingantaccen magani. Bi da bi, masu sayayya suna da aminci ga Actovegin. Bugu da kari, babu wasu madadin magunguna yau. ”

Mai nuna alama.Ru shawarwarin: taka tsantsan motsa jiki

A takaice duk binciken da muka samu. Idan asalin magungunan an kira shi da dubious, to alkhairin yana da ƙarancin samun tabbacin inganci. Masana'antu sun yi imanin cewa babban abu shine wadatar buƙatu, kuma su da kansu sun yarda cewa ba lallai bane a gwada magungunan bisa ga duk ka'idodin magungunan tushen shaidu kafin fara siyarwa. Mafi kyawun “kyakkyawa” kuma biyan bukatun sharuɗan bai cika ba, kawai an buga shirin sa. Shafin yanar gizo na Ingilishi na kamfanin ya ɓoye duk ambaton Actovegin, mai yiwuwa saboda gaskiyar cewa an dakatar da maganin a Kanada da Amurka, wanda ke nufin masana'antun ba su dogara da wannan masu sauraro ba. An haramta amfani da magunguna tare da kayan asalin dabbobi a ƙasashe da yawa saboda haɗarin kamuwa da cututtukan prion.

Dokar Ma'aikatar Lafiya ta Tarayyar Russia ta 15 "A kan matakan hana yaduwar cutar ta Creutzfeldt-Jakob a cikin Tarayyar Rasha" wanda aka sanya a ranar 15 ga Disamba, 2000 ya gabatar da dokar hana shigowa da Rasha ta “nama, nama da sauran kayayyakin yanka daga Burtaniya, Portugal, Switzerland, an iyakance. shigo da wadannan kayayyaki daga sassan tara na Faransa da kananan hukumomi shida na Jamhuriyar Ireland. " Har ila yau, ya ba da shawarar guji shigo da magunguna da aka yi daga glandon ɗan adam na waɗannan yankuna. Koyaya, sabanin irin waɗannan takardu da aka karɓa a Jamhuriyar Belarus da Ukraine, ba a cikin jerin hanyoyin magunguna tare da abubuwan haɗin dabbobi a cikin abubuwan da ke cikin sa, saboda haka, yanzu shigo da Actovegin, wanda aka samar a Switzerland, zuwa Rasha an yarda.

Kasashen gabashin Turai da CIS ba su fada cikin rukuni mai haɗari ba, wanda ke nufin cewa yana yiwuwa a samar da kwayoyi tare da abubuwanda ke da haɗari a cikin ƙasarsu. Amma wannan takaddar tana nuna cewa ga waɗannan ƙasashe, ƙwararrun likitocin WHO ba su da ingantaccen bayani, don haka ba mu san girman girman yiwuwar kamuwa da cutar ba.

Don haka, alhakin wannan shawarar da lafiyar su ya ta'allaka ne da mai siye. Wataƙila ƙwayar tana aiki da gaske, kuma sakamakon gwaji mai kyau a cikin ƙananan mujallolin kimiyya har yanzu gaskiya ne, kuma babban binciken da aka shirya zai tabbatar da su. Koyaya, wannan gaskiyar ba ta dakatar da yiwuwar watsa cututtukan prion ba, don haka ya fi kyau mu guji irin wannan jiyya, aƙalla har sai da tsarin sa ido na tsaro don irin waɗannan abubuwan haɗin ke aiki a cikin magunguna na Rasha.

Ba'a iya daidaita shawarwarinmu tare da nadin likita. Kafin ka fara shan wannan magani ko wannan, tabbatar ka nemi ƙwararrun masani.

Alamu don amfani

Actovegin an yi shi ne ta dalilin hanawar hemoderivative daga jinin maraƙi. Kamar yadda aka riga aka fada, yana karfafa hanyoyin haɓakawa a matakin salula, wanda ke tabbatar da samarda iskar oxygen mafi kyawu ga kyallen da inganta hawan jini. A kan shelves na kantin sayar da kantin magani zaka iya ganin maganin shafawa, gel, allunan da injections.

Yakamata ya kamata a tsara kayan aikin ta hanyar likita kawai. Amma ga gel da maganin shafawa, zasu taimaka tare da ciwan kumburi akan fata, konewa da matsanancin rauni.

Umarnin don amfani yana nuna cewa allunan Actovegin an wajabta su don irin waɗannan yanayin cututtukan kamar:

• bugun jini
• rarrabuwa a cikin kwakwalwa,
• TBI,
• cutar waƙa
• ciwon sukari polyneuropathy,
• cuta na jijiyoyin jiki
• ulcerative tafiyar matakai na trophic yanayi,
• ciwon kai.

Don yin amfani da allurar Actovegin, alamomi iri ɗaya sun dace. Zaɓin nau'in sakin magungunan zai dogara da tsananin yanayin yanayin cutar.

Shawarwarin shan magani

Ana amfani da allurar don injections na ciki da na ciki, Hakanan zai iya zama daddawa.

A matakan farko na maganin jiyya, kashi yana da girma, a kan lokaci ya zama ƙarami. A ƙarshen jiyya, an ba shi izinin maye gurbin inshora na Actovegin tare da allunan. A mafi yawan lokuta, aikin jiyya yana wuce kwanaki 30-45.

Game da nau'in kwamfutar hannu na maganin, dole ne a sha shi a baki. Likitocin galibi suna ba da shawara ga marassa lafiyar su sha Allunan 1-2 sau uku a rana. Bayan an lura da kwanciyar hankali, ana rage adadin yau da kullun.

A cikin ƙuruciya, ana iya ɗaukar magani idan yaron ya kai shekaru uku, kashi ɗaya na yau da kullun shine kwamfutar hannu 1.

Contraindications da m halayen

Kamar kowane magani Actovegin yana da contraindications da yawa, sun haɗa

• oligouria,
• na huhun ciki,
• rashin lafiya
• bugun zuciya
• mutum rashin haƙuri,
• ciki a farkon watanni uku.

Amma game da sakamako masu illa, amfanin wannan magani na iya haifar da:

• rashin lafiyan dauki a cikin hanyar urticaria,
• hyperhidrosis
• increaseara yawan zafin jiki,
• bayyanar itching
• lacrimation
• hyperemia na cutar cizon sauro.

Me yakamata a fifita - allura ko kwayoyin?

Babu amsa ta ƙarshe ga wannan tambaya menene bambanci tsakanin injections da allunan Actovegin da abin da ya fi dacewa a yi amfani da shi, tare da wannan ko wancan yanayin ilimin. Komai zai dogara da nau'in cutar, tsananin yanayin sa, shekarun sa da yanayin halayen mai haƙuri.

Muna ba da misali, idan akwai damuwa na rashin damuwa, zaɓi mafi kyawun magani zai zama nau'in kwamfutar hannu na ƙwayar magani, saboda yana da ikon tarawa cikin ramin jiki. Idan mai haƙuri ba shi da lafiya tare da ciwon sukari, zai fi kyau ba da fifiko ga injections, saboda ta wannan hanyar abu mai aiki yana shiga jiki da sauri kuma yana yada ta.

Idan ya cancanta, za'a iya maye gurbin Actovegin tare da irin waɗannan analogues:

• Cortexin,
• Vero-Trimetazidine,
• Cerebrolysin
• Curantil-25,
• Makasantanta.

Amma game da ampoule, dole ne a tuna cewa ana samun abu mai kama da wannan abu a cikin Solkseril. Farashin zai dogara ne kan ƙasar da aka kirkirar magunguna.

Vidal: https://www.vidal.ru/drugs/actovegin__35582
Radar: https://grls.rosminzdrav.ru/Grls_View_v2.aspx?routingGu>

An sami kuskure? Zaɓi shi kuma latsa Ctrl + Shigar

Bayanin magunguna

Abubuwan da aka haɗa daga maganin Actovegin sune ilimin halittar jiki, don haka ba zai yiwu a yi nazarin likitancin su ba bayan farawa. Magungunan yana inganta tasirin ta hanyar haɓaka metabolism na makamashi. Yana haɓaka amfani da iskar oxygen don haka yana ƙaruwa da juriya ga matsanancin yunwar oxygen a cikin kyallen jikin mutum.

Kamar yadda aka ambata a baya, ta yin amfani da hanyoyin pharmacokinetic, ba shi yiwuwa a yi nazarin halayen pharmacokinetic (ɗaukar ciki, rarrabawa, haɓakawa) na abubuwan da ke cikin aikin Actovegin na miyagun ƙwayoyi, tunda ya ƙunshi kawai kayan aikin kimiyyar lissafi wanda yawanci suna kasancewa a cikin jiki.

Zuwa yau, babu wani dalili don ɗaukar raguwa a cikin tasirin magungunan magungunan ƙwayoyi a cikin marasa lafiya tare da nakasa ayyukan aikin shaye-shaye da ɗebe kayan lalata.

Amfani da magani na tushen shaida, an san cewa Actovegin a cikin nau'i na injections da sauri ya shiga cikin tsarin jini kuma an rarraba abu mai aiki a cikin jiki, wanda ke tabbatar da sakamako mai sauri.

Shaidar tushen magani

Akwai labarai da yawa akan yanar gizo na duniya akan batun cewa babu wani tabbataccen shaida game da tasirin allurar Actovegin sabili da haka ba shi da amfani a yi amfani da shi. Duk hujjojin game da wannan sun dogara ne akan dukkanin abubuwan haɗin kimiyyar guda ɗaya waɗanda ke damun likitoci da yawa.

Amma, akwai irin wannan reshen magani kamar magani na tushen shaidu, wanda a aikace a cikin wani ɗan lokaci ya tabbatar da ingancin wani magani.

Wannan ya faru ne tare da Actovegin, wanda ya kasance sama da shekaru 30 na kasuwar magunguna kuma sake dubawa game da shi yana da matukar inganci duka daga marasa lafiya da kuma daga manyan masana, wanda ke nufin cewa babu wani dalilin yin la'akari da wannan magungunan nootropic mara amfani.

Alamu da contraindications don amfani

Alamu don amfani da Actovegin a cikin hanyar injections:

• neuralgic rikice-rikice (ciki har da ischemic bugun jini, hypoxia, rauni rauni kwakwalwa),
• ciwon sukari mellitus
• take hakkin samarda jini da kuma aikin metabolism,
• varicose veins,
• take hakkin sautin jijiyoyin jiki.

Hakanan ana wajabta magunguna don warkar da rauni mai sauri na raunuka da ƙonewa na digiri dabam-dabam.

Actovegin a cikin ampoules ba shi da maganin hana amfani da shi, amma ba a ba da shawarar bayar da allura ba idan mai haƙuri ya nuna rashin lafiyar ga ɗayan abubuwan wannan magani.

Umarnin don amfani

Amfani da injections na Actovegin cikin hancin ciki ko intramuscularly (ya dogara da digiri da nau'in cutar). A sarrafawa na ciki, ana sanya magani a jujjuyawa ko tsari, kuma kafin gudanarwarsa, an narke maganin a cikin maganin sodium chloride don rushewa da sauri lokacin da ya shiga jiki. A wannan yanayin, sashin yau da kullun ya kamata ya wuce miligram 20.

Amma game da gudanarwar intramuscular, a wannan yanayin, da farko, ya zama dole don zaɓar sashin da ake buƙata. A farkon, suna yin daga milligram 5 zuwa 10 a kowace buguwa kuma, idan ya cancanta, ya karu da milligram 5 a kowane mako. Ana sarrafa allurar ta cikin ciki ba tare da ƙarin magani tare da sodium chloride ba.

Irin waɗannan magungunan nootropic galibi ana amfani dasu yayin da ake fama da rikice-rikice, ciki har da don maganin cututtukan cututtukan cututtukan zuciya.

Yawan sha da yawa da kuma cutarwa

Abin farin ciki, idan yawan maganin da aka ba da shawarar magani ya wuce, to irin wannan kuskuren ba ya tsoratar da mai haƙuri, tunda ba shi yiwuwa ya cutar da jiki tare da abubuwan da ake amfani da shi a cikin Actovegin.

Kamar yadda al'adar ta nuna, mara lafiyar yana karɓar maganin sosai kuma baya haifar da sakamako masu illa. Amma, duk da haka, a cikin lokuta mafi mahimmanci, anaphylactic da halayen rashin lafiyan da ke da alaƙa da rashin yarda da miyagun ƙwayoyi na iya faruwa. Bugu da kari, wadannan sakamako masu illa da suke faruwa wasu lokuta yayin shan Actovegin:

• redanƙan launuka na fatar fata ko ƙura a jiki,
• general malaise
• tashin zuciya da tashin hankali
• ciwon kai da rashi na hankali,
• take hakkin gastrointestinal fili,
• hadin gwiwa zafi
• karancin numfashi, wani lokacin zazzagewa wanda ya haifar da taurin kai a cikin hanyoyin jirgin,
• karuwa da danshi,
• stagnation na ruwa a cikin jiki,
• saboda tsananin girman hanyoyin iska, mara lafiya na iya samun matsaloli hadiye ruwa, abinci da yau,
• wuce kima m jihar da aiki.

Umarni na musamman don amfani

Maƙerin bai bayar da bayani game da ƙarin umarnin game da shan magungunan ba. Amma, yawancin marasa lafiya sun lura cewa tare da ciwon sukari, mai haƙuri ya kamata ya ɗauki miyagun ƙwayoyi a ƙarƙashin kulawar likita, kamar yadda yake riƙe ruwa a cikin jikin mutum, wanda, bi da bi, yana cutar da jiki tare da ciwon sukari.

Nazarin Likita

Babban aikin Actovegin shine haɓaka jigilar oxygen a cikin jini wanda yake yaduwa. Godiya ga abubuwanda suka samar da wannan magani, tsarinsa yana inganta ayyukan haɓakawa a cikin ƙwayoyin jikin mutum sakamakon yawan aiki, tarin, motsi da sakin oxygen da glucose.

Magungunan yana inganta samar da jini zuwa ƙwayoyin nama, yana haɓaka maido da lalacewar kyallen, yana kuma taimaka wa jiki ya sami mahimman abubuwa da abubuwan.

Shigar da Actovegin ga mai haƙuri:

1. Intramuscularly - 5 ml a kowace rana, hanya ta lura - injections 20.
2. Cikin Saurara: a cikin injections na jet - 10 ml a kowace rana, ko an sanya wani daskararre - an narke maganin a cikin 200 ml na saline na jiki ko 5% na glucose. Adadin gudanarwar ya kamata bai wuce 2 ml a minti daya ba.

A kashi na Actovegin ga jiko infusions ya dogara da tsari na pathological tsari, tare da:

• ischemic bugun jini kowane mako, har zuwa 50 ml / rana ana gudanar da shi, sannan a cikin makonni biyu - har zuwa 20 ml / rana,
• rikicewar ƙwayar cuta - sati biyu a 10-20 ml / rana,
• wuya a warkar da lalacewar da amincin fata - 10-20 ml kowace rana.

Mai haƙuri ra'ayi

Yawan aiki a wurin aiki yana ji da kansa, musamman idan ka buɗe ƙaramin kasuwancinka kuma koyaushe yana cikin yanayin damuwa, wanda, ba shakka, yana shafar lafiyarka.

Bayan makonni da yawa na juyayi, sai na fara lura da zazzabin ci gaba, rashin tausayi da ƙonewa a cikin haƙarƙarin. Ban rataye shi a kan wannan ba, saboda na yi tunanin kawai an shimfiɗa ta, amma kullun sai ta yi ta ƙaruwa kuma na tafi wurin likita.

Ya gano ni da intercostal neuralgia hade da damuwa. A matsayin magani, ya umurce ni da Actovegin miyagun ƙwayoyi na nootropic a cikin hanyar injections, kuma a cikin sati daya sai na ji daɗi sosai.

Nikita Milev, ɗan shekara 30

Tun daga ƙuruciya, babbar matsalata ita ce rashin ƙarfi, wanda galibi yakan shafi lafiyata kuma ni ɗan rashin lafiya ne. Lokacin da nake ɗan shekara 19, irin wannan cutar ta sami rauni kamar na herpetic neuralgia - cuta ce da ke damun yankin da idanuwanta.

Nan da nan na je wurin likita, sai ya ba ni maganin Actovegin da ke cikin jijiya kuma bayan makonni 2 cutar ta fara tuntuɓe, kuma bayan wata ɗaya na kawar da ita gaba ɗaya. Af, miyagun ƙwayoyi ma yana haɓaka rigakafi.

Anastasia Shpanina, shekara 20

Shawara mai haƙuri

Abubuwa na maganin Actovegin na iya haifar da rashin lafiyar rashin lafiyar mutum. Yawancin marasa lafiya suna ba da shawarar cewa, lokacin da alamun rashin lafiyan ya faru, ya kamata a cire magungunan don kada su tsananta yanayin.

A matsayinka na mai mulkin, bayan rashin lafiyar rashin lafiyar ta wuce, likita mai halartar zaɓi zaɓi sabon bayani inda babu wasu halayen ƙwayoyin cuta.

Ribobi da fursunoni na m kwarewa

Daga cikin fa'idar da miyagun ƙwayoyi ke fada, ya kamata a rarrabe masu zuwa:

• babban aiki
• 'yan sakamako masu illa
• a cikin lura da rikicewar yanayin neuralgic, maganin likita yana da tasiri mai aiki da magani da kuma tonic,
• kewayon aikace-aikace masu yawa.

Cons: akwai contraindications, gami da halayen rashin lafiyan.

Abun da Actovegin ke ciki a allunan da injections

Tushen maganin Actovegin shine cikakkiyar cirewa daga jinin maraƙi, wanda ke da tasiri mai tasiri na rayuwa.

Abun da ke cikin sa a cikin hanyoyin magance allurar ta dogara da girman ampoule:

• 80 MG na tattara a cikin ampoules tare da 2 ml na bayani,
• 200 MG na mai da hankali - don 5 ampoules 5,
• MG 400 - a cikin ampoules na 10 ml.

A matsayin kayan taimako, ana amfani da ruwa don yin allura.

Aiki mai mahimmanci na nau'in kwamfutar hannu shine Actovegin granrey, i.e. cirewa daga jinin 'yan maruƙa, an haɗe shi da cellulose microcrystalline da povidone K-90. Bugu da kari, kwamfutar hannu zata hada da talc da magnesium stearate azaman kayan taimako.

Maganin tare da intramuscular, intravenous ko drip yana da sauri kuma yana shiga cikin jini gaba daya.

Ruwan da ke kare allunan daga canza kayansu da gudanarwa mai saukin aiki sun hada da glycol wax, dethyl phthalate, talc, titanium dioxide, sucrose, acacia gum, povidone K-30, hypromellose phthalate, macrogol da kuma rigar quinoline rawaya.

Bambanci a cikin nau'ikan maganin

Alamu don ɗaukar Actovegin a cikin allunan ko a cikin hanyar warwarewa, bisa ga umarnin don amfani, kusan iri ɗaya ne. Babban bambanci tsakanin nau'ikan sashi shine cewa mafita, lokacin da aka gudanar da shi ta hanyar intramuscularly, intravenously ko dropwise, yana shiga cikin jini da sauri kuma cikakke, yana samar da jiki tare da babban kashi na abu mai aiki.

Kwayoyin suna shiga cikin jini kawai yayin shakar cikin hanji, i.e. kafin wannan wucewa ta hanyar narkewa. Wannan yana nufin jinkirta lokacin isar da magunguna zuwa ga jini da kuma kawar da shi tare da hanyoyin motsa jiki.